Pablo Sarobe
Instituto de Salud Pública de Navarra
ORCID: 0000-0003-0503-7905Also affiliated with Navarre Institute of Health Research, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma”.
Leyre Silva, Marta Ruiz, Carla Castro-Alejos, Belen Aparicio, Lucia Vegas +4 more
Marta Ruiz, Leyre Silva, David Repáraz, Belén Aparicio, Josune Egea +8 more
Pablo Sarobe, Amaia Lujambio